Inhibition of MAP kinases and down regulation of TNF-α, IL-β and COX-2 genes by the crude extracts from marine bacteria

Biomedicine and Pharmacotherapy

Volumn 63, Issue 7, 2009, Pages 469-476

  Krishnaveni, M ^a   Jayachandran, S ^a  

^a PONDICHERRY UNIVERSITY   (India)

Author keywords

Anti inflammatory; COX; Cytokine; Marine bacteria; Pro inflammatory markers

Indexed keywords

ACETIC ACID ETHYL ESTER; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NATURAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; GENE CONTROL; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MARINE BACTERIUM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLANOCOCCUS MARITIMUS; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS ARLETTAE;

ACETATES; ANTI-INFLAMMATORY AGENTS; BACILLUS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; COMPLEX MIXTURES; CYCLOOXYGENASE 2; DOWN-REGULATION; HUMANS; INTERLEUKIN-1BETA; LYMPHOCYTES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; OCEANS AND SEAS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SOLVENTS; STAPHYLOCOCCUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68049112307     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.09.005     Document Type: Article

References (44)

1. Weissman K. Plumbing new depths in drug discovery. Chem Biol 11 (2004) 743-745
2. Zhang L., Rong A., Wang J., Sun N., Zhang S., Hu J., et al. Exploring novel bioactive compounds from marine microbes. Curr Opin Microbiol 8 (2005) 276-281
3. Berdy J. Bioactive microbial metabolites. J Antibiot 58 (2005) 1-26
4. Balkwill F., Charles K.A., and Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 (2005) 211-217
5. Lin N., Sato T., Takayama Y., Mimaki Y., Sashida Y., Yano M., et al. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol 65 (2003) 2065-2071
6. Nadyne A., Zhu L.P., and Wang G. Identification, phylogenetic characterization, and preliminary bioactivity screening of bacteria isolated from Suberites zeteki, a Hawaiian sponge. J Young Investig 15 (2008). http://www.jyi.org/research/re.php%3Fid%3D869 .
7. Bignold L.P., and Ferrante A. Mechanism of separation of poly-morphonuclear leukocytes from whole blood by the one-step Hypaque-Ficoll method. J Immunol Methods 96 (1987) 29-33
8. Padma B., Clark L.A., and Schneider S. Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells. Curr Med Res Opin 24 (2008) 419-424
9. Nathan C. Inducible nitric oxide synthase: what difference does it make?. J Clin Invest 100 (1997) 2417-2423
10. Payne D.N.R. Nitric oxide in allergic airway inflammation, pediatric asthma and development of atopy. Curr Opin Allergy Clin Immunol 3 (2003) 133-137
11. Nantel F., Denis D., Gordon R., Northey A., Cirino M., Metters K.M., et al. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br J Pharmacol 128 (1999) 853-859
12. Claria J. Cyclooxygenase-2 biology. Curr Pharm Des 9 (2003) 2177-2190
13. Hendel J., and Nielsen O.H. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 92 (1997) 1170-1173
14. Berenbaum F. Proinflammatory cytokines, prostaglandins, and the chondrocyte: mechanisms of intracellular activation. Joint Bone Spine 67 (2000) 561-564
15. Dinarello C.A. Blocking interleukin-1 and tumour necrosis factor in disease. Eur Cytokine Netw 8 (1997) 294-296
16. Camussi G., and Lupia E. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis. Drugs 55 (1998) 613-620
17. Dong C., Davis R.J., and Flavell R.A. Map kinases in the immune response. Annu Rev Immunol 20 (2002) 55-72
18. Blunt J.W., Copp B.R., Munro M.H.G., Northcote P.T., and Prinsep M.R. Marine natural products. Nat Prod Rep 21 (2004) 1-49
19. Manjula N., Gayathri B., Vinaykumar K.S., Shankernarayanan N.P., Vishwakarma R.A., and Balakrishnan A. Inhibition of MAP kinases by extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-alpha, IL-1 beta, IL-2, through the inhibition of transcription factors c-fos and c-jun. Int Immunopharmacol 2 (2006) 122-132
20. Gayathri B., Manjula N., Vinaykumar K.S., Lakshmi B.S., and Balakrishnan A. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFα, IL-1β, NO and MAP kinases. Int Immunopharmacol 7 (2007) 473-482
21. Wu M.H., Tsai W.J., Don M.J., Chen Y.C., Chen I.S., and Kuo Y.C. Tanshinlactone A from Salvia miltiorrhiza modulates interleukin-2 and interferon-γ gene expression. J Ethnopharmacol 113 (2007) 210-217
22. Gao X., Xu Y.X., Janakiraman N., Chapman R.A., and Gautam S.C. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem Pharmacol 62 (2001) 1299-1308
23. Lundblad L.K.A., Thompson-Figueroa J., Leclair T., Sullivan M.J., Poynter M.E., Irvin C.G., et al. Tumor necrosis factor-α overexpression in lung disease a single cause behind a complex phenotype. Am J Respir Crit Care Med 171 (2005) 1363-1370
24. Lee H.J., Hyun E.-A., Yoon W.J., Kim B.H., Rhee M.H., Kang H.K., et al. In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. J Ethnopharmacol 103 (2006) 208-216
25. Lin C.Y., Ku F.M., Kuo Y.C., Chen C.F., Chen W.P., Chen A., et al. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for the treatment of IgA mesangial nephropathy. J Lab Clin Med 133 (1999) 55-63
26. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2 (2001) 907-916
27. Abramson S.B., Amin A.R., Clancy R.M., and Attur M. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 15 (2001) 831-845
28. Rose P., Won Y.K., Ong C.N., and Whiteman M. β-Phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induced production of nitric oxide and prostaglandin E2 in RAW 264.7 macrophages. Nitric Oxide 12 (2005) 237-243
29. Irshad M., and Chaudhuri P.S. Oxidant-antioxidant system: role and significance in human body. Indian J Exp Biol 40 (2002) 1233-1239
30. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 88 (1991) 4651-4655
31. Tetsuka T., Daphna-Iken D., Srivastava S.K., Baier L.D., DuMaine J., and Morrison A.R. Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci U S A 91 (1994) 12168-12172
32. Puybasset L., Bea M.L., Ghaleh B., Giudicelli J.F., and Berdeaux A. Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs. Circ Res 79 (1996) 343-357
33. Belmont H.M., Levartovsky D., Goel A., Amin A., Giorno R., Rediske J., et al. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1810-1816
34. Cryer B., and Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 104 (1998) 413-421
35. Touhey S., Connor R.O., Plunkett S., Maguire A., and Clynes M. Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition. Identification of novel chemotherapeutic drug resistance modulators. Eur J Cancer 38 (2002) 1661-1670
36. Lu H.T., Yang D.D., Wysk M., Gatti E., Mellman I., Davis R.J., et al. Defective IL-12 production in mitogen activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J 18 (1990) 1845-1857
37. Singh D., Aggarwal A., Mathias A., and Naik S. Immunomodulatory activity of Semecarpus anacardium extract in mononuclear cells of normal individuals and rheumatoid arthritis patients. J Ethnopharmacol 108 (2006) 398-406
38. Kimmatkar N., Thawani V., Hingorani L., and Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - a randomized double blind placebo controlled trial. Phytomedicine 10 1 (2003) 3-7
39. Sakuma S., Kato Y., Nishigaki F., Magari K., Miyata S., Ohkubo Y., et al. Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro. Int Immunopharmacol 1 (2001) 749-757
40. Apte R.N., and Voronov E. Interleukin-1 - a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol 12 (2002) 277-290
41. Hommes D.W., Peppelenbosch M.P., and Van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52 (2003) 144-151
42. Foey A.D., Parry S.L., Williams L.M., Feldmann M., Foxwell B.M.J., and Brennan F.M. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol 160 (1998) 920-928
43. Wurzel H., Yeh C.C., Gairola C., and Chow C.K. Oxidative damage and antioxidant status in the lungs and bronchoalveolar lavage fluid of rats exposed chronically to cigarette smoke. J Biochem Toxicol 10 (1995) 11-17
44. Bingisser R., Stey C., Weller M., Groscurth P., Russi E., and Frei K. Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. Am J Respir Cell Mol Biol 1 (1996) 64-70